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Abstract
Activation-induced cytidine deaminase (AID) is expressed in B cells within germinal centers and is critically involved in class
switch recombination and somatic hypermutation of immunoglobulin loci. Functionally active AID can additionally be
detected within ectopic follicular structures developed at sites of chronic inflammation. Furthermore, AID may target non-Ig
genes in B- and non-B-cell background. Therefore, AID-associated effects are of increasing interest in disease areas such as
allergy, inflammation, autoimmunity, and cancer. Pathway- or disease-relevant multigene signatures have attracted
substantial attention for therapeutic target proposal, diagnostic tools, and monitoring of therapy response. To delineate the
impact of AID in etiology of multifactorial diseases, we designed the AID-associated 25-gene signature. Chronic
rhinosinusitis with nasal polyps was used as an inflammation-driven airway disease model; high levels of IgE have been
previously shown to be present within polyp tissue. Expression levels of 16 genes were found to be modulated in polyps
including AID, IgG and IgE mature transcripts which reflect AID activity; clustering algorithm revealed an AID-specific gene
signature for the disease state with nasal polyp. Complementary, AID-positive ectopic lymphoid structures were detected
within polyp tissues by in situ immunostaining. Our data demonstrate the class switch recombination and somatic
hypermutation events likely taking place locally in the airways and in addition to the previously highlighted markers and/or
targets as IL5 and IgE suggest novel candidate genes to be considered for treatment of nasal polyposis including among
others IL13 and CD23. Thus, the algorithm presented herein including the multigene signature approach, analysis of co-
regularities and creation of AID-associated functional network gives an integrated view of biological processes and might
be further applied to assess role of altered AID expression in etiology of other diseases, in particular, aberrant immunity and
cancer.
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Introduction
Adaptive immunity mechanisms ensure specificity for foreign
antigenswith virtuallyunlimiteddiversityduringdifferentiationofT
and B lymphocytes. In contrast to T cells, B lymphocytes have
developedtwoadditionalindependentstepsto further diversifytheir
receptors after antigen collision: somatic hypermutation (SHM) and
class-switch recombination (CSR). Both SHM and CSR critically
depend on the expression of activation-induced cytidine deaminase
(AID) [1,2]. AID is a member of the APOBEC family of cytidine
deaminases, which acts via introduction of single-strand breaks into
target DNA through deamination of cytosine for conversion to
uracil. AID is currently considered as the only B-cell-specific factor
required to trigger both SHM and CSR, when DNA breaks are
specifically introduced into the variable or switch regions of Ig
genes, respectively [3,4]. In germinal centers (GCs) the AID
expression is transient and is initiated in early centroblasts, is
maximal in full-blown centroblasts, significantly decreases in
centrocytes and is downregulated in plasma cells [5]. Additionally,
AID-positive cells could be detected outside the GCs; a major
fraction of this type of AID-positive cells resides within the subset of
interfollicular large B lymphocytes [6,7].
Clearly, such a potent mutagenic and recombinogenic enzyme
needs to be tightly regulated at different levels to minimize the risk
of unwanted DNA damage. A number of mechanisms restricting
AID expression/activity to distinct cell types, time frames and
target loci were identified [8–13]. Nevertheless, recent findings
indicate that the presence of ectopic lymphoid structures can be
detected in chronically inflamed tissues in several autoimmune
disorders [14]; in synovium of rheumatoid arthritis the AID-
positive follicular structures are directly implemented in promoting
the production of pathogenic autoantibodies [15]. Local expres-
sion of AID and class switch recombination to IgE was shown in
the bronchial mucosa of atopic and nonatopic patients with
asthma [16] and within the oesophageal mucosa of patients with
chronic oesophagitis [17].
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allow AID to target non-Ig genes within genomic DNA [18–21].
Thus, aberrantly expressed and/or aberrantly regulated AID may
function as a general, genome-wide mutator [22] being involved in
disease development of different etiology. AID as a node gene and
the subsequent AID-associated events therefore receive increasing
attention in disease areas such as inflammation, autoimmunity and
cancer.
The phenotypic heterogeneity of human diseases presents a
major challenge to advancing our in-depth understanding of
disease mechanisms. However, there is good evidence to believe
that establishment and validation of gene-, pathway-, or disease-
relevant signatures provide tools for understanding the functional
relevance of gene alterations in human diseases – not only for basic
research but also for therapeutic target proposal, diagnostic tools,
and monitoring of therapy response [23–26]. Different methods
may be applied to address the role of a functional gene module in
the etiology of a multifactorial disease at the level of gene
alterations: (i) the in silico data-driven approach is based on the
analysis of available microarray datasets and dissects gene-
associated pathways into meaningful modules; the data analysis
offer the advantage of a transcriptome-wide screening procedure
but often lack the sensitivity for genes expressed at a low levels; (ii)
a knowledge-driven approach uses a self-designed gene signature.
In this case, a core set of interacting genes is assembled based on
mining the scientific literature and/or with the help of bioinfor-
matics, and is subsequently applied for the real-time PCR-based
gene expression profiling. This methodology offers the detailed
characterization of the input of one particular pathway while
keeping limited amount of genes at the beginning of the study.
Important advantage, on the other side, is the high sensitivity and
reproducibility allowing quantitative profiling even of low-copy
genes which are below the detection limits of microarray
platforms. In the current study, we used the knowledge-driven
approach to create an AID-associated 25-gene signature. This
signature was evaluated in a disease model of benign, chronically
inflamed tissue, namely in nasal polyposis. Chronic rhinosinusitis
without nasal polyps, characterized by a modest inflammatory
reaction, was used for immunopathological comparison as control
tissue [27]. Nasal polyps are considered to be a model for
persistent severe airway disease and do share the Th2-bias and the
polyclonal IgE production with asthma, as recently shown [28].
Th2-cytokines and IgE also link nasal polyps to comorbid asthma,
as demonstrated by the analysis of factors within the polyp tissue,
which are associated with asthma [29]. The immunopathological
mechanisms underlying the nasal polyp formation are not
completely resolved. Whereas the focus of investigations was on
T-cells and their subpopulations [30–32], the impact of B-cells has
scarcely been analysed. B lymphocyte infiltrations – diffuse
accumulations and those organized to follicles [33], B cell
attractant chemokines [34] and high levels of IgE type antibodies
were shown to be present within polyp tissue [35,36]. Thus,
expression of functional AID within nasal polyp tissue has been
presumed but never conclusively demonstrated. The approach
presented herein allows assessing the role of AID-associated events
in the molecular mechanisms underlying the initiation and/or
progression of an inflammation-driven disease.
Methods
Profile of study patients
A panel of 33 specimens of nasal mucosal tissues from patients
with chronic rhinosinusitis without nasal polyps (CRS; n=15) and
with nasal polyps (NP; n=18) was obtained from the Department
of Oto-Rhino-Laryngology of the University Hospital of Ghent,
Belgium. All samples were obtained during routine endonasal
sinus surgery in consecutive patients scheduled for surgery
unrelated to the study. The diagnosis of sinus disease was based
on history, clinical examination, nasal endoscopy and CT-scan of
the sinuses according to the EP3OS guidelines [37] None of the
subjects used oral or nasal corticosteroids four weeks before
surgery or antibiotics within the last two weeks. All patients
provided written informed consent, and the ethics committee of
the Ghent University Hospital approved the study. Clinical
parameters including history of atopy, asthma, aspirin hypersen-
sitivity (ASA), total IgE antibody levels, IgE specific to Staphylo-
coccus aureus enterotoxins (SAE-IgE), levels of eosinophil cationic
protein (ECP) and IL5 in tissue homogenates are summarized in
Table S1. Samples processing and measurement procedures were
performed as described [33]. Each sample was separated to
proceed with protein and total RNA isolation as described [33].
Primer design, real-time PCR analysis, data visualization,
pathway analysis, statistics
Gene expression profiling was performed by real-time PCR on
ABI PRISM 7900HT (Applied Biosystems) in 96-well plates using
the SYBR Green detection system as described [38]. Primers were
designed using ‘‘Primer Express 2.0’’ software and validated using
a normal tissue panel (Takara, Clontech). Algorithm for detection
of IgM, IgG, and IgE mature transcripts and results of BLAST
analysis of IgG forward and reverse primers are available as
Table S2. Sequence for CD23b was reconstructed based on the
comparison of virtually translated nucleotide sequence of intron 2
of CD23 gene and previously published N-terminal amino acid
sequence of CD23b variant [39]. For relative quantification, data
were analyzed by DDCT method using SDS 2.3. (Applied
Biosystems) and normalized to the average of housekeeping genes
(HKG) as elongation factor (EF1A), beta 2 microglobulin (b2M),
actin b (ACTB), and ubiquitin C (UBC). For the absolute gene
quantification, plasmid overexpressing gene of interest was used as
external standard [40,41]. Plasmids expressing the full-length AID
(pUHD10S-Flag-AID-fl) and the naturally occurring splice variant
with the truncated C-terminus (pUHD10S-Flag-AID-dE4) were
kindly provided by Prof. Xiaosheng Wu [13]; plasmid encoding
full-length human ACTB was from Invitrogen. Cluster 3.0 and
TreeView programs (http://bonsai.hgc.jp/,mdehoon/software/
cluster/manual/index.html) were used for computational analysis
and graphical representation of datasets. The data-driven, AID-
associated gene network was created using the Ingenuity Pathway
Analysis Software (http://www.ingenuity.com). Statistical analyses
were performed using GraphPad Prism 5.0 and SYSTAT 12
programs. Differences between diseased groups and alignments
with clinical parameters were analyzed using log2 values of
variances. For Student t tests, 2-way analysis of variance, p values
of 0.05 or less were considered significant.
AID-associated 25-gene signature
Based on the knowledge-driven approach of B cell biology and
NP data mining, a signature of AID-associated genes was
assembled. The 25-gene ‘‘AID signature’’ includes the full-length
AID-FL and the alternative AID splice variant AID-Dex4;
activators and suppressors in AID regulation such as PAX5,
IRF8, ID2, ID3, EGR1/2/3 [42–44]; immune cell markers as
CD19, CD3, CD14, CD86, CD21L [15,45]; Th2 cytokines as
IL5, IL13 (IL4 was excluded based on the trace levels of expression
in both diseased groups); low and high affinity IgE receptors as
CD23 (variant a and b), FceRI alpha, beta and gamma subunits;
IgM, IgG, IgE mature transcripts. Tables with NCBI accession
AID-Associated Multigene Signature
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functional gene descriptions are available as supplementary files
(Table S3, Table S4). In summary, the composition of the
signature created around AID as a node gene allows to assess AID
expression and AID activity as proven by the class switch
recombination-based formation of IgG and IgE mature tran-
scripts; the presence of tissue infiltrating immune cells such as B
cells, T cells, monocytes, and follicular dendritic cells being
indicative for various stages of lymphoid organization; the
expression pattern of low- and high-affinity IgE receptors
mediating numerous IgE-related immune responses; and Th2
polarization.
Immunostaining on paraffin-embedded tissue sections
and AID-positive Raji cell line
Raji, lymphoblastoid cells derived from a Burkitt lymphoma,
were obtained from ATCC (Manassas, VA). Cytospins of Raji cells
were fixed with methanol/acetone solution (1:1 v:v) for 12 min at
220 Cu. Immunofluorescence with Raji cells was generally
performed as described [38]. Paraffin blocks of disease specimens
were prepared using the complete isolated tissue; these disease
specimens do not overlap with patient population taken for gene
expression profiling. Paraffin-embedded 5 mm-thick sections
underwent routine staining with haematoxilin and eosin. Sections
of NP specimens with lymphoid aggregates displaying a radial cell
number greater than 10 cells (n=5) and sections of CRS patients
(n=4) were taken for CD20 and AID staining. To detect AID, two
different antibodies were used: clone ZA001 mouse IgG1-kappa
(Invitrogen) and clone EK2-5G9 rat IgG2b (Cell Signaling). ; anti-
AID antibodies were previously shown to be functional in
immunostaining of cells transfected with the plasmid encoding
AID [12] and of AID-positive cells in paraffin-embedded tissue
sections [46,47]. For immunohistochemistry method, DAKO
EnVision+, Peroxidase system (DAKO, Glostrup, Denmark) was
used. Sections were counterstained with haematoxylin for nuclear
visualization. Alternatively, a fluorescent staining with biotinylated
rabbit anti-rat Ig or anti-mouse Ig secondary antibodies (Invitro-
gen, Paisley, UK) followed by streptavidin conjugated to Alexa
dyes was used (Invitrogen, Paisley, UK). Nuclear counterstaining
was performed with DAPI (Roche, Mannheim, Germany). In our
experimental settings, both anti-AID antibodies showed identical
results (data not shown); immunohistochemistry method was
preferable to immunofluorescence for AID staining within NP
tissues. CD138 (clone BA38, from AbD Seroteck, Oxford, UK)
was used as a marker for plasma cells [48]; CD20 (clone L26, from
Thermo Scientific, Cheshire WA7 1PR, UK) was used as general
B cell marker. Polyclonal Rabbit Anti-Human IgE was from
DAKO (Glostrup, Denmark). TissueFAXS (TissueGnostics,
Vienna, Austria), a fully automated multi-channel immunofluo-
rescence tissue analysis system was used for the acquisition of
diseased specimen/paraffin-embedded tissues as well as of Raji
cells. For acquisition the 20x/0.5 or the 40x/1.3-oil objectives
were used (EC Plan_NeoFluar, Zeiss). Filter sets were from
Chroma TechnologyCorp (DAPI 350/460 nm; FITC/Cy2 470/
525 nm; TxRed/Cy5 620/700 nm). Images were processed using
Adobe Photoshop CS2 software.
Results
Expression profiling of functional AID in specimens from
patients with chronic rhinosinusitis without or with nasal
polyps
We designed primer pairs to detect AID mRNA of human
origin and performed expression profiling in normal tissues
(multiple tissue panels, Clontech) (Text S1 and Figure S1).
Furthermore, we established a real-time PCR-based approach to
detect IgM, IgG (total), and IgE mature transcripts within the
same specimen. This highly sensitive and quantitative method can
be routinely used for detection of Ig transcripts within the tissues
from large cohort of samples. Detection of IgG or IgE mature
transcripts was used to assess AID activity as the ability to produce
different isotypes of antibodies is a functional consequence of the
active AID molecule. We next analyzed the AID expression
pattern in specimens from patients with chronic rhinosinusitis
without nasal polyps (CRS) in comparison to the one with nasal
polyps (NP). Within the pilot experiment, six CRS samples and
nine NP samples were profiled. As shown on Figure 1, CRS
samples were characterized by non-detectable or trace AID
mRNA levels, whereas strongly elevated expression levels of AID
indicative for initiation of class switch recombination were
detected in 3 out of 9 NP samples. Marked inter-patient variability
of AID mRNA levels within the NP group might be explained by
the transient nature of AID expression and/or various stages of B
cell response for each individual. IgG total mRNA levels were
significantly increased in the NP group in comparison to the CRS
patients (p,0.01). IgE were detected at trace amounts in CRS,
while being strongly elevated in the NP group (p,0.001). In
contrast, IgM mature transcripts were detected in both CRS and
NP groups characterizing the presence of B cells in both diseased
groups. Of note, strongly enhanced AID expression detected in
NP2, NP6, and NP9 was associated with elevated expression of
either IgE and/or IgG mature transcripts. Furthermore, subpop-
ulation within the NP group, characterized by the moderate AID
expression, showed increased IgE and/or IgG expression levels. In
line, absence of AID expression in the CRS group was
accompanied by non-detectable or low IgE and IgG transcription,
while levels of AID-independent IgM transcription were compa-
rable to those of the NP group. Partially overlapping expression
patterns of AID and IgG/IgE mature transcripts within the NP
group might be explained by the transient nature of both AID and
IgG/IgE transcription and the time-shift in kinetics between these
two events - the preceding AID expression followed by the AID-
mediated CSR resulting in the production of Ig isotype switched
mature transcripts [49]. Of particular importance, a strong
positive correlation (r=0.747; p,0.001) was found between IgE
mature transcript levels estimated by real-time PCR technique and
total IgE protein levels determined in supernatants after tissue
homogenization (Table S1). These data suggest (i) the AID-
positive B cells to be present within NP tissue; (ii) at least part of
detectable IgE protein within NP is based on AID-driven CSR.
Comparative profiling of AID-FL and the splice variant
Alternative splicing may be a potential mechanism that controls
AID action under physiological conditions. The naturally
occurring splice variant lacking exon 4, AID-Dex4 (AY536517),
encodes a C-terminally truncated product, which is characterized
by the complete lack of CSR activity, while showing hyper-SHM
activity [13]. Herein, we compared mRNA levels of the full-length
AID transcript, AID-FL, and of the splice variant AID-Dex4
within the same tissue. The panel under investigation was
composed from normal human tissues which were found to be
AID-positive on the mRNA level (data are available as Figure S1
and detailed in Text S1) and NP specimens; lymph node (total
RNA, Ambion) was included as a positive control. The ratio
between AID-FL and AID-Dex4 was characterized by a strong
inter-tissue variability (Table 1). Thus, in salivary gland, thymus,
thyroid gland, lymph node, NP2, and NP6 the AID-FL mRNA
levels exceeded those of the AID-Dex4 variant, while in the tissues
AID-Associated Multigene Signature
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was comparable to or higher than the full-length transcript (e.g.
NP4, NP5). The results indicate occurrence of alternative splicing
in vivo.
AID-positive ectopic lymphoid structures within nasal
polyp tissues assayed by in situ immunostaining
Enhanced AID expression in NP tissues detected by real-time
PCR may be based on increased migration of activated B cells
and/or ectopic expression. Therefore, to estimate ectopic
lymphoid structure formation and presence of AID-positive cells,
in situ immunostaining analysis of NP specimens was performed.
Tonsils (a secondary lymphoid organ with fully organized
functional GC structures) and the Raji cell line were used as
reference tissue/cell type for AID expression. As expected,
immunofluorescent staining of tonsils for CD20 revealed strong
expression in the GCs of lymphoid follicles (Figure 2, A, a). CD20
immunostaining analysis of NP specimens revealed that lympho-
cytic infiltrates are able to evolve into follicular structures
(Figure 2, A, c, d); the data are in line with previously published
observations [33]. Lymphoid follicles developed within NP tissues
differed from those in tonsils in morphology; thus, the mantel zone
characteristic for active GCs within tonsils (Figure 2, B, merged,
a; DAPI, d; CD20, g) was not fully established in NP-derived
follicular structures (Figure 2, B, merged, b; DAPI, e; CD20, h)
likely suggesting their transient nature. Different patterns of B cell
accumulations were found to coexist within the same specimen; in
addition to CD20-positive follicles, B cell aggregates around the
glandular structures, the subepithelial mucosal glands contributing
to the secretion of mucus, composed of more than fifty CD20-
positive cells could be detected (Figure 2, B, merged, c; DAPI, f;
CD20, i).
To visualize the AID protein expression, immunofluorescent or
immunohistochemical staining protocols were established as
demonstrated for Raji cells on Figure S2; however, immunohis-
tochemistry was superior to AID staining for NP tissues.
Immunohistochemical staining of tonsils revealed strong AID
expression in the GC; in fully developed GC, AID staining was
predominantly seen in the dark zone (Figure 2, C, a). Consistent
Figure 1. Expression profiles of AID and Ig transcripts in individual samples of patients with chronic rhinosinusitis without (CRS) or
with nasal polyps (NP) assayed by real-time PCR. Expression profiles were analyzed using the DDCT method for relative quantification.
Expression levels of full-length AID (AID-FL), mature transcripts of IgM, IgG total, and IgE mRNAs were normalized to the average of HKGs and shown
relative to CRS1. Results are shown as mean values in one experiment 6 SD and are representative of two independent runs.
doi:10.1371/journal.pone.0025611.g001
Table 1. Comparative analysis of AID-FL and AID-Dex4 mRNA
levels.
tissue AID-FL AID-Dex4 ratio
AID-FL:AID-Dex4
bone marrow 12.1963.3 8.1663.1 1.49
kidney 15.4663.1 39.4663.4 0.39
salivary gland 180.85641.9 53.2864.6 3.39
thymus 539.11657.2 62.5668.2 8.62
thyroid gland 168.17643.9 50.65611.2 3.32
lymph node 1658.69693.3 209.39611.9 7.92
NP2 284.85665.6 60.33613.4 4.72
NP3 40.93612.0 35.1366.4 1.17
NP4 13.5864.4 38.67611.0 0.35
NP5 44.41613.5 75.5619.6 0.59
NP6 264.70637.9 41.98611.7 6.31
An absolute quantification was performed using recombinant DNA-based
external standards (Standard Curve Assay Getting Started Guide, Applied
Biosystems). Efficiency and linearity of the standard curve (R
2) for AID-FL, AID-
Dex4, and ACTB were EAID-FL=1.99, R
2
AID-FL=0.999; EAID-Dex4=2.03, R
2
AID-Dex4
=0.998; EAID-FL=1.99, R
2
AID-FL=0.999; EActin=2.01, R
2
Actin=0.999. Results are
expressed as absolute cDNA copy number of target gene per 10
6 copy numbers
of ACTB as HKG. Shown are mean values from three independent experiments
each performed in duplicate 6 SEM.
doi:10.1371/journal.pone.0025611.t001
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as well readily detected (Figure 2, C, b). Within NP tissues, AID-
positive B cells were predominantly localized within the follicular
structures (Figure 2, C, c). Of note, CD20-positive lymphocytic
aggregates around the glandular structures, which were not
organized into follicles, were found to be negative for AID
expression (Figure S3). In contrast to NP tissues, no CD20-positive
follicular structures were detected within CRS specimens; similarly
to NP, lymphocytic non-follicular aggregates were AID-negative
(data not shown).
In addition, within NP tissues the CD138-positive plasma cells
were found to be localized outside the follicular structures
(Figure 2, D), which is in line with the knowledge that plasma
cells do not express the CD20 marker [6]. Additional areas
showing accumulation of CD138-positive cells were found in the
close proximity to the boarder of the polyp tissue body (Figure 2,
D) and to the glandular structures. IgE-positive cells of different
intensities were readily detected within the same areas as CD138-
positive cells and in addition within follicular structures (Figure 2,
E). Double staining for IgE and CD138 confirmed the presence of
an IgE-positive B-cell subset (Figure 2, F); single stained IgE-
positive cells might be attributed to an effector cell population
based on the bi-lobed form of the nuclei (e.g. eosinophils,
basophils; Figure S4).
In summary, detection of AID and mature IgE transcripts by
real-time PCR analysis accompanied by immunostaining data
suggest that the nasal polyp tissue might contain functionally
active, AID-positive ectopic follicular structures. Thus, the data
indicate that nasal polyposis is a relevant disease model to study
AID-associated responses with a presence of ongoing class switch
recombination in benign, chronically inflamed tissues.
AID-associated gene expression signature: linking gene
expression data with a functional network
A panel of 33 clinically characterized samples with chronic
rhinosinusitis without nasal polyps (CRS; n=15) and with nasal
polyps (NP; n=18) was profiled with primer sets from the 25-gene
‘‘AID signature’’ specified in Methods and Tables S2–S4. Genes
significantly affected in NP in comparison to CRS (p,0.05 –
p,0.0001) were identified: upregulated AID, IL13, IL5, CD23
Figure 2. AID expression in nasal polyp tissues assessed by in
situ immunostaining. (A) CD20 staining in fully developed GCs in
tonsil tissue (CD20, a; isotype control, b) and two representative NP
specimens (c, d); scale bar: 500 mm. (B) CD20 staining: higher power
views of GC in tonsil (a) and of two types of B cell infiltrates in NP as
prominent follicles (b) and accumulations around the glandular
structures (c) are shown. In addition to the merged images (a, b, c;
red channel for CD20 and blue channel for DAPI), pictures of individual
channels are included (d, e, f for DAPI; g, h, i for CD20); the presence of
the mantel zone in fully established GC within tonsil tissues is indicated
by a white dotted line. Scale bar: 50 mm. In Figure 2, the individual
channels are shown in black/white, whereas merged images are shown
in color. (C) AID-positive GCs in tonsil tissue (a, the low-power view; b,
the higher-power view) and follicular structures within NP with AID-
positive cells (c) are shown; Scale bar for a is 1000 mm; scale bar for b, c
is 50 mm. (D) Two areas representative for accumulation of CD138-
positive cells within NP tissues are shown: around follicular structures
(merged, a; DAPI, c; CD138,e) and in the close proximity to the boarder
of NP body (merged, b; DAPI, d; CD138, f). Scale bar: 50 mm. (E)
Representative pictures of IgE-positive cells detected within follicular
structures and their surrounding cell populations and within B cell
aggregates around the glandular structures (merged a, b; DAPI, c, d; IgE,
e, f). Scale bar: 50 mm. (F) Double staining of IgE (green) and CD138
(red) within NP (merged a; DAPI, b; IgE, c; CD138, d); insert: example of
double positive B cell is shown. Scale bar: 50 mm.
doi:10.1371/journal.pone.0025611.g002
AID-Associated Multigene Signature
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25611total and CD23a, CD23b isoforms, FceRIa, FceRIb, and FceRIg
subunits, IgG and IgE mature transcripts, CD14, CD19, CD86,
PAX5 (tendency; p=0.06), IRF8; downregulated ID3 (Figure 3).
Next, we performed an alignment of expression datasets with the
patient’s clinical parameters (summarized in Table S1) such as
sex, history of atopy, asthma, and aspirin hypersensitivity (ASA).
Data analysis revealed significant associations between (i) atopy
and CD23/CD23b, IL13, IL5, CD19, CD86, CD14, IgG, IgE,
FceRIa, FceRIg, and ID3; (ii) asthma and CD23/CD23a/CD23b,
IL13, IL5, CD19, CD14, IgG, FceRIg, AID (tendency, p=0.051),
and IgE (tendency, p=0.052) (Table S5). No associations with sex
or ASA were found.
Hierarchical cluster analysis was used for further data interpre-
tationand visualization. This algorithm arrangesthe data into a tree
structure providing information about the relationship between the
samples and between the genes [50]. The samples fall into two main
clusters, separatingmajoritiesofCRSand NPsamples with onlyfew
samples forming a mixed population (Figure 4, A). Furthermore,
two gene sub-signatures emerged. Sub-signature 1 can be
designated as AID-associated (n=11 genes). Within this sub-
signature, the AID-positive cluster contained a higher number of
NP samples, while the AID-negative cluster contained the majority
of CRS specimens. Hierarchical clustering revealed close associa-
tions between subset of genes IL13–IL5–CD23b–CD23–IgE–
CD23a–FceRIb, which are further linked to AID–CD19–IgG–
PAX5. Estimated coefficients of correlation were found to be .0.6,
p,0.0001 for IL5–CD23/CD23b, IL13–IL5, IL13–IgE, IL13–
CD23/CD23a/CD23b (for all genes, Pearson correlation matrix
and matrix of probabilities, matrix of Bonferroni corrected
probabilities are available as Table S6). Of importance, AID was
Figure 3. Differential expression of AID-associated genes in specimens with nasal polyps (NP) in comparison to the one without
nasal polyps (CRS). (A) Box-plot analysis of gene expression profiling dataset of CRS (n=15) and NP (n=18) specimens. The box represents the
distribution of values; a line across the box represents the median; the box stretches from the lower hinge (the 25th percentile) to the upper hinge
(the 75th percentile). p value is shown for each gene (t test for log2 values of variances). All modulated genes with the significant difference between
two diseased groups, including AID, passed the Holm-Bonferroni correction for multiple testing.
doi:10.1371/journal.pone.0025611.g003
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p,0.0001) with IL13, IL5, CD19, CD23, CD23a, and PAX5. AID
showed less stringent positive correlation with IgG mature
transcripts (correlation coefficient=0.471, p=0.005) and IgE
(correlation coefficient=0.417, p=0.014). Partially overlapping
time-courses and transient nature of both AID and IgG/IgE
transcription might explain these results [42]. No significant
correlation was found between AID expression and expression
pattern of CD21L, an isoform specifically expressed by follicular
dendritic cells [15,45]. No significant correlation was revealed
between AID full-length transcript and AID-Dex4. Sub-signature 2
(n=11) was formed around the transcriptional repressors ID2/ID3;
splice variant AID-Dex4 was included in this gene cluster. Inverse to
the sub-signature 1, higher expression values were characteristic for
CRS specimens and the CRS/NP mixed population, while the NP
group presented with lower values.
Patient-orientated gene expression pattern
Arrangement of datasets for each specimen across all genes is
able to provide the gene expression pattern characteristic for each
individual sample and therefore being patient-orientated. Scatter
plots of three patients from the CRS group (CRS2, CRS9,
CRS11) and three patients from the NP group (NP6, NP9, NP18)
are shown on Figure 4, B. The patients were selected from two
main sample clusters separating CRS and NP groups and
therefore are representative for each group. As expected, the
disease-group-characteristic gene distribution patterns are evi-
dent; however, the patient-specific differences within gene
expression signature are apparent as well. Of importance, scatter
plots of CRS specimens from the clustering-based mixed
population (CRS8, CRS10 and CRS12) differed from both
CRS-specific and NP-specific patterns showing rather the
intermediate stage.
Figure 4. Hierarchical clustering of expression datasets and scatter plots of patient-orientated profile. (A) The subset of 25 genes was
analyzed against a dataset derived from the real-time PCR-based profiling of a panel of 33 specimens from patients with chronic rhinosinusitis with
nasal polyps (NP; n=18) in comparison to the one without nasal polyps (CRS; n=15); Pearson uncentered hierarchical clustering was applied. Shown
is a result of a clustering run representing a pair of trees, one for genes and one for arrays/samples (Cluster/TreeView programs). Sub-signatures 1 and
2 orchestrated around AID and IDs/AID-Dex4 (AIDdelEx4 here), respectively, are indicated. Color code: red indicates induction and green - repression;
according to Cluster/TreeView [50], color hue does not reflect the exact magnitude of gene alteration. (B) log transformation plots represent the
patient-orientated gene expression ‘‘fingerprint’’; the figure depicts the relative expression level of each gene between CRS or NP specimens (y-axis)
and CRS3 specimen (x-axis); axis – log scale. Representative scatter plots of three patients from the CRS group (CRS2, CRS9, CRS11) and three patients
from the NP group (NP6, NP9, NP18) are shown. These specimens were selected from two main clusters, separating CRS and NP samples (Figure 4, A).
Scatter plots of three CRS specimens (CRS8, CRS10, CRS12) from a mixed population are shown in addition.
doi:10.1371/journal.pone.0025611.g004
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Disease-relevant multigene signatures have attracted substantial
attention for therapeutic target proposal, diagnostic tools, and
monitoring of therapy response [23,24,26]. Development of
diagnostic and/or prognostic signatures considered to be an
important step towards personalized medicine. To assess the role
of B cell-driven responses associated with altered AID expression,
we used a self-created gene signature to perform a comparative
analysis of the transcriptional programs characteristic for chronic
rhinosinusitis with or without nasal polyps. The composition of the
25-gene signature allows to estimate (i) the presence of tissue
infiltrating immune cells such as B cells, T cells, monocytes, and
follicular dendritic cells, (ii) AID expression (the full length and
AID-Dex4), (iii) AID activity proven by the class switch
recombination-based formation of IgG and IgE mature tran-
scripts, (iv) various stages of lymphoid organization, (v) the
expression pattern of low- and high-affinity IgE receptors
mediating numerous IgE-related immune responses. This core
set of genes, which is of particular relevance for inflammatory and
allergic disorders, may be further extended with additional
candidate genes using bioinformatics approaches to fulfil the
criteria for other disorders.
Chronic rhinosinusitis was used as an inflammation-driven
disease model. Disease development of chronic rhinosinusitis
might take different directions; despite ongoing progress in
research [27,29,32,51,52], it is yet unclear what mechanisms
drive the disease towards the nasal polyp formation. In this study
we provide, to our knowledge, the first demonstration that AID
(the full-length transcript and the splice variant) is expressed within
the nasal polyp tissue. Profiling of B cell markers (e.g. IgM
transcripts, PAX5, CD23a, CD19) is indicative for the presence of
infiltrating B cells in tissues of both diseased groups; yet
comparison of gene expression patterns using a 25-gene signature
confirmed an AID-associated signature for the disease state with
NP (summary Figure 5). AID indicates initiation of CSR. Mature
IgE transcripts, resulting from DNA excision and ligation of the
V(D)J sequences to the constant epsilon region, indicate the
presence of IgE-switched B cells. The expression profiling data are
supported by immunostaining which demonstrate the existence of
AID-positive ectopic follicular structures and IgE-switched B cells
within nasal polyp tissue, suggesting class switch recombination
and somatic hypermutation events to take place locally in the
airways – at least for the sub-group within NP population.
Complementary to local maturation and priming for class
switching, increased migration of activated B cells into NP tissue
and accumulation of long-lived plasma cells producing high levels
of IgE antibodies cannot be excluded as an additional mechanism
as suggested in recent study of Patadja et al [34]. The biological
responses initiated within ectopic follicular structures may have
various regulatory functions influencing the disease pathogenesis
and/or disease resolution. Given the focus of the current study to
the multigene signature approach, an open question remains
whether a number of AID-positive follicles developed within polyp
tissue correlate with clinical parameters.
Here, we report the results of comparative profiling of the AID-
FL and the splice variant AID-Dex4 encoding a C-terminally
truncated product; the latter was demonstrated to have strictly
different enzymatic activity compared to the full-length transcript
[13]. Furthermore, the C-terminus contains a determinant for
AID cytoplasmic retention, which hampers diffusion to the
nucleus, competes with nuclear import and is crucial for
maintaining the predominantly cytoplasmic localization of AID
[12]. Therefore, the analysis and quantification of AID-Dex4
mRNA, predicted and confirmed ([53] and DM, unpublished) to
give rise to a C-terminally truncated AID protein with increased
resident time in the nucleus, is of particular interest. It is essential
to note that both AID-FL and AID-Dex4 mRNAs can be detected
in NP specimens and in some normal non-lymphatic tissues as well
(Table 1). One example of AID-positive tissue is thymus. The fact
of AID expression in the thymic medulla at the mRNA as well as
functional protein level was noted previously [7]; however, the
biological relevance of AID expression within a B cell subset in the
thymus of adults under physiological conditions is still poorly
understood. For the majority of tissues under investigation the
AID-FL mRNA levels exceeded those of the AID-Dex4 variant;
keeping in mind constant nuclear localization of AID-Dex4 protein
transcript, even low expression levels might have significant
functional consequences. The method applied in the current study
does not allow to determine whether AID-FL and AID-Dex4 are
both expressed within the same cell or in different cells in a ‘‘one
variant per cell’’ pattern as discussed recently by Wu et al [13].
During normal, physiological responses the sequential expression
of AID variants may occur. Initial B-cell activation may trigger
full-length AID expression, which drives predominantly the Ig
class switch recombination processes; while at a later phase, the
Figure 5. AID-associated gene network. Multigene signature-
based network displaying AID as a key gene was created using the
Ingenuity Pathway Analysis Software (IPA; http://www.ingenuity.com).
The color code of transcripts indicates up- (red) and down-regulation
(green) of genes in the NP disease group in comparison to rhinosinusitis
without polyps. Solid lines in grey display the IPA-identified direct
associations between transcripts; solid lines in red or in blue reflect the
IPA-identified associations overlapping with the 25-gene-identified
molecular interactions. The multigene approach including the analysis
of co-regularities can be extended to find not-yet-identified functional
links between the genes under investigation; statistically significant,
study-based biological associations (SYSTAT program; Table S6) are
displayed by dashed lines; color code: red for correlation coefficient
$0.6, p,0.0001; blue for correlation coefficient ,0.6, p,0.05.
doi:10.1371/journal.pone.0025611.g005
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characterized by a strong hyper-mutational potential, additionally
modulates the affinity of the available antibody repertoire. The
AID-Dex4 truncated transcript may be stored in memory and/or
plasma cells; preferential expression of AID-Dex4 in plasma cells
was indeed demonstrated [13]. Despite we did not find any specific
expression pattern of AID-Dex4 in nasal polyps, the established
algorithm can be further applied to test the hypothesis whether the
ratio [AID-FL: AID-Dex4] might have a prognostic value for
certain diseased conditions including chronic inflammation,
autoimmunity, and cancer and/or might correlate with an
increased potential for AID off-target effects.
It is of importance, that the multigene signature approach
applied in the current study allows to differentiate the state of
development/organization of lymphoid structures occurring at
sites of chronic inflammation and/or recurrent antigenic stimu-
lation; this is based on the analysis of associations between AID
and the follicular dendritic cell marker CD21L [15,45]. Thus, the
study of Humby and colleagues [15] provided strong evidence that
ectopic lymphoid structures formed within the synovial membrane
of patients with rheumatoid arthritis were characterized by the
presence of both AID-positive B cells and CD21L-positive
follicular dendritic cells; moreover, a significant positive correla-
tion was found between expression patterns of AID and CD21L
mRNA. Therefore, these lymphoid aggregates were attributed to
follicular structures resembling GCs. In the case of NP tissues, we
could not detect significantly increased CD21L mRNA levels in
patients with polyps; furthermore, no correlation was found
between AID and CD21L expression patterns. Thus, organization
and possibly functionality of lymphoid aggregates seem to be
different to those described in chronically inflamed tissues in
patients with rheumatoid arthritis. Follicular structures within NP
tissue were found to be functionally active but not entirely
organized as GCs. The data are in agreement with ongoing
discussions that the forces driving B cells to form unique classes of
active follicular structures with specialized functions are diverse
and robust [54].
PAX5 - the unique transcription factor of B cell identity, which
is necessary and sufficient for B cell development from the pro-B
cell to the mature B cell stage [55–57] was detected in both
diseased groups, however, with tendency for enhanced expression
in NP. PAX5 functions both as a transcriptional repressor and as
an activator on different target genes. Thus, among others, it
represses Notch1 [57] and FLT3 [58] and it activates CD19 [59],
BLNK [60], and AID [61]. Furthermore, the unexpected close
correlation between AID and CD23 shown in the present study
suggests a common transcriptional network in the regulation of
these genes. Given that CD23 and particularly CD23a, showed a
positive correlation to PAX5, one would predict that PAX5 is a
candidate transcription factor involved in the upregulation of both
AID and CD23 in B cells. Indeed, functional PAX5 binding site(s)
were previously identified within the CD23a promoter [62].
Thus, some of the identified regularities in gene distribution
patterns have already been proven by other groups in cell-based
assays. Therefore, the multigene approach presented herein
including the analysis of co-regularities can be further extended
to find not-yet-identified functional links between the genes under
investigation (Figure 5). Of interest, expression of FceRIg mRNA
(signaling subunit of the high affinity IgE receptor) was
upregulated in the NP group. Furthermore, the expression pattern
of FceRIg was found to correlate positively with those of CD14,
CD86, FceRIa as well as with AID, CD19, CD23, IgE and IgG
transcripts, IRF8 and PAX5. Correlation with B cell identity
markers suggests that FceRIg transcription could be triggered in B
cells at a certain stage of their activation. Of note, FceRIa – the
functional extracellular subunit of the FceRI receptor complex –
did not reveal the list of regularities described above. Thus, the
FceRI receptor complex might be regulated via the signaling
gamma chain whereas the alpha chain is constitutively ‘‘ready’’.
Alternatively, the FceRIg chain might build up a signaling
complex with other activating receptors besides FceRIa. Indeed,
such examples were previously described for other cell types: when
expressed by plasmacytoid dendritic cells, FceRIg was found to
cooperate with BDCA2 [63]; on a subset of Treg cells, FceRIg
chain functions within the TCR complex [64]. For B cells, a
functional cooperation partner for FceRIg besides FceRIa has not
yet been demonstrated to our knowledge.
Remarkable data suggest that EGR (early growth response)
family members might also be involved in AID-associated
biological responses [42,65] including the fact that Egr-1 null
mice showed increased levels of serum IgE [43]. Thus, according
to our working hypothesis this transcription factor may be a
regulatory player in the AID-associated network. However,
expression profiling revealed only a tendency for reduced
expression of EGR-1 mRNA in NP in comparison to the levels
in rhinosinusitis without polyps, possibly ‘‘masked’’ by those cell
types in NP tissue with steady or increased EGR-1 expression.
Nevertheless, clustering and correlation analysis revealed clear
associations of EGR family members with the transcriptional
repressors ID2/ID3 jointly forming the AID-Dex4-included sub-
signature 2. Thus, our data suggest a repressor function of the
EGR-1 transcription factor in functionally active follicular
structures.
IL5 was included as a positive control gene in the current study.
The specific knowledge on the role of IL5 in CRS with NP as
discovered previously [66] and the possibility of IL5 antagonism in
vitro [67] led to the clinical application of humanized anti-IL5
antibodies for the treatment of nasal polyposis [68,69]. However,
only a subgroup of patients responded to this treatment pointing to
the heterogeneity of the disease etiology on the one side, and of the
patient population on the other side. Additionally, the data
indicated that further target gene(s) might be considered for
treatment of disease in single therapy or combined therapy with
anti-IL5 agents. Gene profiling data of the current study revealed
(i) a significant increase of IL13 mRNA levels in NP tissues, (ii)
significant associations with the clinical parameters such as atopy
and asthma, and (iii) a strong positive correlation between
expression levels of IL13 and IL5. In line, elevated protein levels
of IL13 were shown previously in a subgroup of CRS patients with
polyposis [70], and IL13 is spontaneously released from NP tissue
[71]. Furthermore, IL13 is considered to be a critical regulator of
inflammatory and allergic responses [72] and, at the same time, as
shown in mouse models, the IL13-triggered signaling cascades and
downstream gene expression patterns are only partially overlap-
ping with those induced by other Th2 cytokines [73]. Thus, our
results suggest that IL13 is a candidate target for treatment of nasal
polyposis.
Another potential candidate target gene strongly associated with
AID and IgE molecules is CD23 (Figure 5). CD23, the low-
affinity IgE receptor, is expressed on a variety of hematopoietic cell
types [74–76]. CD23 has been shown to play a role in modulating
the production of IgE by B cells [74,77]. CD23 mediates
numerous IgE-related immune responses (including antigen
focusing) by enhancing IgE antigen complex presentation,
regulating IgE synthesis, influencing cell differentiation and
growth of both B and T cells, and stimulating the production of
pro-inflammatory mediators from monocytes/macrophages, eo-
sinophils, and even some types of stromal cells [76]. There are two
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CD23a and CD23b differ at the N-terminus and display different
patterns of expression and sensitivities to exogenous stimuli [78].
Thus, expression of CD23a is largely restricted to B cells, while
CD23b synthesis is inducible in a variety of cells upon exogenous
stimulation. The tools developed in the current study allowed us to
perform comparative profiling of individual transcripts as well as
the total CD23 molecule content within the same tissue. Given the
significant increase of CD23 mRNA levels including the individual
variants in polyp tissues, significant associations with patient’s
clinical parameters such as atopy and asthma, and the positive
correlations between IL5–CD23/CD23b, IL13–CD23, CD23a–
PAX5, and AID–CD23/CD23a it might therefore be of interest to
further investigate whether CD23 might serve as drug target for
the local treatment of polyposis. Currently, Lumiliximab – a
chimeric macaque and human anti-CD23 monoclonal antibody –
is considered as immunomodulator and is in clinical trials for the
treatment of patients with chronic lymphocytic leukemia [79].
Besides leukemia, an anti-CD23 strategy has previously been
considered for the treatment of asthma, allergic inflammation, and
atopic dermatitis [80].
A final observation is based on the arrangement of datasets for
each specimen across all genes. This approach provides the
patient-specific gene expression ‘‘fingerprint’’. Of particular
interest are the patterns of specimens from the CRS group, which
cluster within the mixed population. These specimens are
distinguished based on the elevated levels of subset of genes
characteristic for the NP group (e.g. IL5, CD23, IL13). The data
suggest the described approach to be supportive for the patient-
orientated therapeutic targeting and for the definition of new
predictive factors in clinical monitoring.
Taken together, we have developed a multigene signature
covering one particular disease-associated module using AID as
the key gene. We further explored associations between AID and
other molecules involved in the etiology of human inflammation-
driven disease such as nasal polyposis: in addition to the previously
highlighted biomarkers/targets [35,70], novel players were
suggested including among others IL13 and CD23 as well as
genes of B cell identity. Thus, the algorithm presented herein
based on the multigene signature approach, analysis of co-
regularities and creation of AID-associated functional network
gives an integrated view of biological processes and might be
further applied to clarify role of altered AID expression in etiology
of other diseases including autoimmune and malignant disorders.
Supporting Information
Figure S1 Expression profiles of AID in mouse and
human tissues assayed by real-time PCR. Expression levels
of AID genes were normalized to the average of HKGs and shown
relative (A) to salivary gland for mouse tissues and (B) to adrenal
gland for human tissues. Results are shown as mean values from
triplicates in one experiment 6 SD and are representative of two
independent experiments.
(EPS)
Figure S2 AID expression in Raji cells assessed by
immunostaining. Cytospin preparations from Raji cells. AID
expression was detected using either immunofluorescence or
immunohistochemistry protocols (AID, a, b; isotype control, c, d).
(a) 89.5% of cells (2532 analysed cells) were calculated to be AID-
positive (TissueQuest software; TissueGnostics, Vienna, Austria);
(b) 80.9% of cells (2647 analysed cells) were calculated to be AID-
positive (HistoQuest software; TissueGnostics, Vienna, Austria).
(EPS)
Figure S3 AID expression in nasal polyp tissues assess-
ed by in situ immunostaining. AID-positive cells were not
detected within B cell population around the glandular structures.
Scale bar: 50 mm.
(EPS)
Figure S4 Single stained IgE-positive cells within NP.
Representative examples of single stained IgE-positive/CD138-
negative cells are indicated by asterisks. The individual channels
for DAPI, IgE and CD138 are shown as black/white and the
merged images are in color.
(EPS)
Table S1 Profile of study patients. Clinical parameters
including history of atopy, asthma, aspirin hypersensitivity (ASA),
total IgE antibody levels, IgE specific to Staphylococcus aureus
enterotoxins (SAE-IgE), levels of eosinophil cationic protein (ECP)
and IL5 are indicated. BDL, below detection limit; ND, not
determined.
(DOC)
Table S2 BLAST analysis of IgG forward and reverse
primers. Gene symbol, NCBI GeneID, results of BLAST search
are provided. Forward primer sequence (indicated in the Table as
‘‘Query’’) was subjected to NCBI BLAST analysis. Results showed
100% homology to the IGHJ1/4/5 transcripts (indicated in the
table as ‘‘Sbjct’’. Tm of forward primer is 64uC and therefore this
is allows to bind to the template with mismatch. IGH is an
abbreviation for immunoglobulin heavy join, thereby confirmed
the ability to detect IGH classes. Reverse primer sequence
(indicated in the Table as ‘‘Query’’) was subjected to NCBI
BLAST analysis. Results showed 100% homology to the IGHG1/
2/3/4 transcripts (indicated in the table as ‘‘Sbjct’’; IGHG is an
abbreviation for immunoglobulin heavy constant gamma), thereby
confirmed the ability to detect all IgG isotypes.
(DOC)
Table S3 Real-time PCR primers. Gene symbol and
synonyms, NCBI accession number, sequences of forward (F)
and reverse (R) primers.
(DOC)
Table S4 A panel of human genes. Gene symbol and
synonyms, NCBI accession number, short functional gene
description from Gene/NCBI are provided.
(DOC)
Table S5 Alignment of expression profiling dataset with
the clinical parameters. Comparisons between gene expres-
sion datasets (log2-transformed values) and patient’s clinical
parameters such as sex, history of atopy, asthma, and aspirin
hypersensitivity (ASA) (from Table S1) are summarized. Analysis
was done across both diseased groups. p value color code: red,
statistically significant; blue, tendency; bold, passed the Holm-
Bonferroni correction method for multiple comparisons.
(DOC)
Table S6 Correlation analysis (SYSTAT program).
Pearson correlation matrix and the corresponding matrix of
probabilities as well as matrix of Bonferroni probabilities are shown.
The analysis was performed across all samples of two disease groups.
Lines for protein transcripts are highlighted in grey. Color code for
statistically significant co-regularities: red for correlation coeffi-
cient$0.6, p,0.0001; blue for correlation coefficient,0.6, p,0.05.
(PDF)
Text S1 Results.
(DOC)
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